Accepted at 11:43 p.m. Oct, 31, 2023 by Ahmed7
Author: ChetLow
Related Note: 1495735525371
Rationale for change

feels more familiar?

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#OME_banner #AK_Step1_v12::#B&B::12_Hematology::04_Cancer_Drugs::06_Other_Cancer_Drugs #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::03_Kinase_Inhibitors_&_Monoclonal_Antibodies::02_Monoclonal_Antibody_Therapy::zanki_extra #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::18_Anticancer_monoclonal_antibodies::*Trastuzumab #AK_Step2_v12::#B&B::11_Obstetrics_and_Gynecology::03_Breast::02_Breast_cancer #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::11_Cell_Cycle_Independent_Drug_Targets #AK_Step1_v12::#UWorld::#UWSA1 #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies::02_Other_applications::*Trastuzumab #AK_Step1_v12::#AMBOSS::k4amjk #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::11_Cell_Cycle_Independent_Drug_Targets #AK_Step1_v12::#AMBOSS::R4alQk #AK_Step1_v12::^Other::^EXPN